yes indeed they could have purchased that company and all it had developed for less, its like GPP are fine tuning this for the rest of the world to come and grab a slice of, Thermaquatica arent coughing up any money only GPP, and they only get the rights to manufacture in Australia and NZ, there is something seriously wrong in that alone,
- Forums
- ASX - By Stock
- GNM
- Ann: Appendix 3B Placement
Ann: Appendix 3B Placement, page-66
Featured News
Add GNM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.855M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 674997 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 23334 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 674997 | 0.011 |
5 | 1329995 | 0.010 |
3 | 883330 | 0.009 |
2 | 440000 | 0.008 |
2 | 229999 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 23334 | 1 |
0.015 | 202325 | 1 |
0.016 | 12803 | 1 |
0.017 | 227673 | 2 |
0.018 | 416660 | 3 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
GNM (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online